S&P 500
5,945.17
-0.4%
-$25.64
DJI
42,353.75
-0.2%
-$73.99
NASDAQ
19,316.96
-0.7%
-$143.53
Bitcoin
102,451.00
-2.5%
-2,577.72
AAPL
$200.66
-1.1%
-$2.16
AMZN
$208.52
+0.6%
+$1.29
GOOG
$170.05
+0.4%
+$0.66
META
$685.72
-0.3%
-$2.23
MSFT
$468.01
+0.9%
+$4.14
NVDA
$140.19
-1.2%
-$1.73
TSLA
$284.68
-14.3%
-$47.37
Eileen Rojas
er529
Eileen has been a Foolish Contributor since 2013 focusing on consumer goods and healthcare. She has a Master's and Bachelor's degree in Accounting from Florida International University.
Recent Articles by Eileen Rojas

Dec 3, 2013
by Eileen Rojas
Statins Take Center Stage in Treating High Cholesterol
New guidelines on the treatment of high cholesterol recommend the use of statin drugs, which could result in higher sales of statins at AstraZeneca (NYSE: AZN, Mylan Labs (Nasdaq: MYL), and Teva Pharmaceuticals (NYSE: TEVA).
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.